Evidence map›Paper›PMID 40755704›Full record

ArticleCureus2025

Comparison of Intraocular Lens Stability and Reversibility in Phacovitrectomy With Air or Gas Tamponade Using One- and Three-Piece Intraocular Lenses.

Yuji Yoshikawa, Jun Makita, Kei Shinoda

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuji YoshikawaOphthalmology, Saitama Medical University Hospital, Saitama, JPN.
Jun MakitaOphthalmology, Saitama Medical University Hospital, Saitama, JPN.
Kei ShinodaOphthalmology, Saitama Medical University Hospital, Saitama, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose To compare intraocular lens (IOL) stability and reversibility in phacovitrectomy with air or gas tamponade between one- and three-piece intraocular lenses (IOLs). Study design This retrospective cross-sectional study was conducted at Saitama Medical University Hospital from January to July 2023. Methods This study involved 19 patients who underwent phacovitrectomy with either air or sulfur hexafluoride gas tamponade and postoperative anterior segment optical coherence tomography. Patients who underwent NSP-3 (NIDEK Co., Ltd., Japan) or NX70s (Santen Pharmaceutical Co., Japan) implantation were evaluated. The displacement force (mN) of the IOL was evaluated in a verification experiment using the NSP-2 (NIDEK Co., Ltd., Japan) and the NX70s. The NSP-2 and NSP-3 share the same lens platform.   Results The median age was 66 (58, 77) [median (quartiles)] years for NX70s (n=8) and 67 (55, 71) years for NSP-3 (n=11). The anterior chamber depth (ACD) and IOL position values were substantially elevated after the air or gas disappeared for both IOLs. Comparing the IOLs for the ACD and IOL positions at each time point, no significant difference was found in the ACD and IOL position values in 100% gas or air. However, ACD and IOL position values of the NSP-3 were markedly higher than those of the NX70s in 0% gas or air. In the verification experiment, NSP-2 required a higher IOL displacement force than the NX70s. Following 48 h of 0.5 mm push, the percentage change in the axial distance was smaller for NSP-2 (-6.9%) than for NX70s (-15.5%). Conclusion NSP3 was as stable as NX70s in phacovitrectomy with tamponade and demonstrated better reversibility than NX70s.

Indexed as

anterior chamber depthgas tamponadeintraocular lens displacementintraocular lens positionphacovitrectomy

Identifiers

PMID40755704
PMCPMC12318166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.